SAFE

Research SAFE (ALSAF.PA) on Bullrun: market cap EUR 127.51K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 127.51K.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 5.36M-EUR 4.67M-EUR 2.15M67.5%-0.02EUR 390.00KEUR 13.50M-EUR 10.68M
FY2024EUR 5.04M-EUR 1.93B-EUR 3.36M52.6%-1410000EUR 317.00KEUR 11.79M-EUR 8.42M
FY2023EUR 5.81M-EUR 205.44MEUR 64.69M74.4%-18676727.27EUR 780.00KEUR 271.21M-EUR 202.36M
FY2022EUR 5.86M-EUR 6.97M-EUR 6.33M67.0%-90EUR 302.00KEUR 10.11M-EUR 1.28M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-10EUR 127.51Kn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About SAFE

Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is SAFE's market cap?

SAFE's market capitalization is EUR 127.51K.

What does SAFE do?

Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut.